Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by ...
Pharmaceutical Technology on MSN

CSL to pump $1.5bn into US plasma supply chain

CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.
A little over five years ago, the Trump administration announced Operation Warp Speed to deliver a vaccine for COVID-19. It was one of the most stunning successes of Trump’s first term. Recognizing a ...
Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...